About Us

James is an experienced financial, strategic, operational, and transactional professional who has executed on more than $2B in aggregate transaction value. James has spent over a decade working on behalf of companies at various stages in their life cycle from start-up and emerging growth to mature commercial-stage businesses. He has advised on a range of traditional and complex transaction types and structures spanning M&A, licensing and partnerships, option agreements, and financings for both the buy and sell side. James has significant cross-border experience having executed transactions on behalf of and involving companies across the EU and APAC.

James has considerable experience with company formation activities and direct operational experience leading businesses from inception through hyper growth phases of their life cycle. He has advised and worked across the life science industry with direct experience in the biopharmaceutical (across all major therapeutic areas), med tech, & healthcare services sectors.

James is the Chief Financial & Strategy Officer of Moximed, a commercial-stage orthopedic device company backed by blue-chip life science investors including NEA, Advent, Gilde, Vertex Ventures, Elevage (Patient Square Capital), Future Fund (Australia Sovereign Wealth Fund), and Cormorant Asset Management. Additionally, James is a Corporate Advisory Board Member at SutureTech Inc (orthopedic medical device company) and Akeeko Medical (urology medical device company).

Prior to joining Moximed, James was a founding team member & Chief Business Officer and Board Member of the wholly-owned Japan Subsidiary at Palette Life Sciences, Inc an interventional urology medical device company. James joined Palette at its inception and was critical in executing on The Company’s spin-out transaction with Nestle Skin Health, developing & implementing Palette’s business model, and company formation activities. James was instrumental in driving Palette’s exit via acquisition by Teleflex, Inc for $650M in 2023. While at Palette, James oversaw Sales Operations, Sales Analytics, ex-US commercial, global reimbursement & market access, finance, strategy, and business development functions. Prior to joining Palette, James was on the senior team at Back Bay Life Science Advisors, a life science focused investment banking and strategy consulting firm.

In addition to his operating roles, James is the Founder and Managing Partner of Warren Point Capital, LLC (WPC), a growth equity med-tech investment firm. James founded Warren Point Capital (WPC) in late 2020 to capitalize on his unique access to med-tech investment opportunities, gained from his experience and relationships as a med-tech operator and banker / strategy consultant. WPC has since invested >$20M across over a dozen growth stage med-tech companies.

James started his career as an Analyst with JSB-Partners, a life sciences-focused transaction advisory firm and has prior experience covering the healthcare services industry at Provident Healthcare Partners, a Boston-based healthcare investment bank. James graduated summa cum laude from the University of Rhode Island with a BS in Finance. While at URI, James was Captain of the Men’s Rowing Team.